Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wooshin Labottach is a specialized pharmaceutical and healthcare company headquartered in South Korea, with a significant research and distribution presence in Slovenia. The company focuses on the development and manufacturing of advanced drug delivery systems, specifically proprietary hydrogel-based transdermal and topical patches. Their product portfolio includes a wide range of medical devices, cosmeceuticals, and food supplements designed for pain management, dermatological care, and general wellness. Wooshin Labottach leverages its Transdermal Drug Delivery System (TDDS) platform to provide innovative solutions for both over-the-counter and professional markets. In addition to its own brands, the company operates as a contract manufacturing organization (CMO) for global partners seeking specialized patch formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wooshin Labottach.